We have located links that may give you full text access.
Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents.
American Journal of Ophthalmology 1983 September
Sixteen patients (ten women and six men, ranging in age from 20 to 67 years) with active bilateral posterior uveitis of noninfectious origin were treated with cyclosporin A, a specific anti-T-cell medication. All had previously received systemic corticosteroids or cytotoxic agents or both and had responded poorly or had intolerable side effects. Fifteen of 16 patients had positive responses to oral cyclosporin A therapy (initially 10 mg/kg of body weight/day), measured by a decrease in inflammatory activity, with a concomitant improvement in visual acuity in most patients. Fluorescein angiographic findings varied considerably with some patients showing an improvement with continued cystoid macular edema. Renal toxicity occurred in five patients, but renal function reverted toward normal with a decrease in cyclosporin A dosage.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app